2009Perspectives In Psychiatric CareOpen access

Atypical Antipsychotic Drugs: Part 1

Norman L. Keltner, Heather Coffeen, Janna E. Johnson

Open full text 3 citations

Abstract

This column on atypical antipsychotics is the first of two parts. Part I consists of a review of foundational information and a discussion on clozapine and risperidone. Part II will address olanzapine, quetiapine, and ziprasidone.

Open-access reader

About this research paper

What this paper is about

This column on atypical antipsychotics is the first of two parts. Part I consists of a review of foundational information and a discussion on clozapine and risperidone. Part II will address olanzapine, quetiapine, and ziprasidone.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This column on atypical antipsychotics is the first of two parts. Part I consists of a review of foundational information and a discussion on clozapine and risperidone. Part II will address olanzapine, quetiapine, and ziprasidone.

Key concepts: Ziprasidone, Quetiapine, Olanzapine, Risperidone, Clozapine, Atypical antipsychotic, Medicine, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Atypical Antipsychotic Drugs: Part 1 — Research Paper | ScholarLens